Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

826
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
826
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.3K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.9K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.7K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

420
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
420

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supplemental Oxygen Strategies in children with BronchoPulmonary Dysplasia (the SOS BPD study): statistical analysis plan for a multicenter randomized controlled trial.

Trials·2026
Same author

Investigating the impact of poly(beta amino) ester-mediated FOXJ1 mRNA delivery on differentiation of primary human bronchial epithelial cells.

Biology open·2026
Same author

Dynamics of nasal transcriptomics during step-up treatment in children with uncontrolled asthma.

The Journal of allergy and clinical immunology·2026
Same author

Find your career: the ERS "My Career Path" series.

Breathe (Sheffield, England)·2026
Same author

Reply.

The Journal of allergy and clinical immunology·2026
Same author

Inhaled Acinetobacter lwoffii exposure promotes lung PD-L1<sup>+</sup> neutrophils and dampens viral-induced type 2 immunity.

Mucosal immunology·2026

Related Experiment Video

Updated: Oct 15, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.6K

Childhood asthma: pathogenesis and phenotypes.

Mariëlle W Pijnenburg1, Urs Frey2, Johan C De Jongste3

  • 1Dept of Paediatrics, Division of Respiratory Medicine and Allergology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands m.pijnenburg@erasmusmc.nl.

The European Respiratory Journal
|October 29, 2021
PubMed
Summary
This summary is machine-generated.

Childhood asthma development involves type 2 inflammation, influenced by genetics, environment, and microbiome. Identifying distinct phenotypes and endotypes is key to personalized asthma diagnosis and treatment.

More Related Videos

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.4K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.8K

Related Experiment Videos

Last Updated: Oct 15, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

40.6K
Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
12:08

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells

Published on: March 10, 2016

11.4K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.8K

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Environmental Health

Background:

  • Childhood asthma pathogenesis is driven by type 2 inflammation, shaped by early life exposures.
  • Interactions between infections, genetics, atopy, and environmental factors (pollution, smoke) impact wheezing illness and asthma risk.
  • Microbiome dysbiosis, infant weight gain, and preterm birth are critical factors in asthma development and reduced lung function.

Purpose of the Study:

  • To explore the complex interplay of factors contributing to childhood asthma heterogeneity.
  • To highlight the importance of identifying pediatric asthma phenotypes and endotypes for improved diagnosis and treatment.
  • To discuss the potential of data-driven approaches for defining asthma phenotypes and enabling personalized medicine.

Main Methods:

  • Review of current knowledge on the pathogenesis of childhood asthma.
  • Analysis of factors influencing asthma development, including immune responses, lung function, and microbiome.
  • Discussion of clinical parameters and pathophysiological mechanisms for identifying asthma phenotypes and endotypes.

Main Results:

  • Childhood asthma is characterized by heterogeneity due to complex interactions between various risk factors.
  • Phenotypes (clinical) and endotypes (pathophysiological) can be identified in pediatric asthma.
  • Inflammatory phenotypes have successfully guided biological treatments for severe, therapy-resistant childhood asthma.

Conclusions:

  • Understanding asthma heterogeneity through phenotypes and endotypes is crucial for personalized pediatric asthma care.
  • Data-driven clustering and systems biology approaches may refine asthma phenotype definitions.
  • Personalized treatment options for childhood asthma are expanding, particularly for severe cases, based on identified phenotypes.